e-Therapeutics plc Outlines Goals for 2012 and Announces Presentation at Biotech Showcase Conference
1/9/2012 7:08:04 AM
OXFORD & NEWCASTLE, England--(BUSINESS WIRE)--Drug discovery and development company e-Therapeutics plc (AIM: ETX) today provides an update on its goals and expectations for 2012.
•Four drugs to enter clinical trials
?ETS2101 (anti-cancer drug; phase I programme starting in Q1)
?ETX1153c (phase I trial for C. difficile infection starting in Q2)